Current Edition

How-Has-the-COVID-19-Pandemic-Amplified
Volume 3 Issue 3

How Has the COVID-19 Pandemic Amplified the Importance of the IVD Industry?

As the world is still coming to grips with the COVID-19 pandemic, the role of IVD in detecting, and thus helping in finding an appropriate …

Continue Reading →
DRUG DEVELOPMENT
Volume 3 Issue 3

The Benefits of Outsourcing for Early-stage Drug Development

The investment drug companies are making into producing biosimilars has never been greater. This major push is driven by the faster time to market of …

Continue Reading →
New-Wave-of-R&D-Points
Volume 3 Issue 3

New Wave of R&D Points the Way to Tackling the Oldest Enemy

The COVID-19 pandemic has forced businesses of every kind to adjust and pivot, demolishing all manner of received wisdom along the way. The changing environment …

Continue Reading →
Base Editing
Volume 3 Issue 3

Base Editing, the Story So Far

Gene editing technologies have been evolving since CRISPR was first commercialised in early 2012. The recent emergence of CRISPR base editing platforms has attracted attention …

Continue Reading →
RE-MODELLING-DRUG
Volume 3 Issue 3

Re-modelling Drug Delivery Services for High-viscosity Formulations

Biologic formulations for subcutaneous delivery allow patients to self-administer their treatment and reduce the need for them to consult hospital-based healthcare practitioners. Intravenous formulations are …

Continue Reading →
A Global Approach to Nitrosamine Impurity Testing
Nitrosamine

A Global Approach to Nitrosamine Impurity Testing for Drug Products

Manufacturers and regulatory authorities around the world are now aware of the potential threat posed by nitrosamine impurities in API/DP. By taking a global, collaborative …

Continue Reading →
Transforming the Healthcare Landscape with Synthetic
Volume 3 Issue 3

Transforming the Healthcare Landscape with Synthetic Biology and Living Medicines

There is a well-recognised global need for therapeutic options for diseases that are deemed difficult to treat or are currently untreatable. The emergence of synthetic …

Continue Reading →
Helping Labs Operate at Peak Efficiency
Volume 3 Issue 3

Helping Labs Operate at Peak Efficiency to Foster Innovation

Science, as Vannevar Bush wrote, is an endless frontier. Bush, the founder of Raytheon and Director of the Office of Science and Development at its …

Continue Reading →
The Solution to Improve Profitability in Pharmaceutical
Volume 3 Issue 3

The Solution to Improve Profitability in Pharmaceutical Development; How to Increase Pre-clinical Productivity and Success Rates in Clinical Trials

The limited availability and usage of pre-clinical laboratory instruments which provide biologically relevant data has resulted in unnecessarily high failure rates of pharmaceutical drug candidates …

Continue Reading →
Tightly Coupling the Laboratory to the Pharmaceutical
Volume 3 Issue 3

Tightly Coupling the Laboratory to the Pharmaceutical Manufacturing Process is Essential to Success

All manufacturing flows – whether making cars, food products, medical devices, or pharmaceuticals – take raw materials, and through a series of manufacturing processes, transform …

Continue Reading →
Key Challenges and Potential Solutions for Optimising
Volume 3 Issue 3

Key Challenges and Potential Solutions for Optimising Downstream Bioprocessing Production

The dramatic growth in the use of biologics across multiple therapeutic applications and categories will only continue to increase. As the demand for these drugs …

Continue Reading →
Building a Gene Therapy_Challenges and Changes in Viral Vector Manufacture
Volume 3 Issue 3

Building a Gene Therapy: Challenges and Changes in Viral Vector Manufacture

Retroviruses were an attractive first choice for viral vectors for gene therapy because the DNA they encode – either wildtype viral DNA or the therapeutic …

Continue Reading →
Compliance Capacity_A Checklist to Assess Regulatory Readiness
Volume 3 Issue 3

Compliance Capacity: A Checklist to Assess Regulatory Readiness

As life science businesses focus on managing the impact of COVID-19 and working on solutions to fight this pandemic, regulatory responsibilities remain a pressing concern …

Continue Reading →
Hydrogel Encapsulation – The New Paradigm for Ambient
Volume 3 Issue 3

Hydrogel Encapsulation – The New Paradigm for Ambient Temperature Cell Shipping

Deep freezing has become the standard practice for long-term preservation of biological samples, especially for isolated and cultured cells. Its use has been extended to …

Continue Reading →
Driving Demand for Parenteral Packaging_How Biologics
Volume 3 Issue 3

Driving Demand for Parenteral Packaging: How Biologics are Changing the Face of Pharma Packaging?

The biopharmaceutical sector has enjoyed robust and sustained growth in recent years. A recent BioPlan Associates report estimates worldwide sales of biopharma treatments reached more …

Continue Reading →